A detailed history of Gamma Investing LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 1,310 shares of CTLT stock, worth $80,289. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,310
Previous 1,032 26.94%
Holding current value
$80,289
Previous $58 Million 36.74%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$56.16 - $60.96 $15,612 - $16,946
278 Added 26.94%
1,310 $79.3 Million
Q2 2024

Jul 02, 2024

BUY
$53.58 - $57.02 $11,358 - $12,088
212 Added 25.85%
1,032 $58 Million
Q1 2024

Apr 05, 2024

BUY
$42.56 - $59.82 $3,575 - $5,024
84 Added 11.41%
820 $46.3 Million
Q4 2023

Feb 01, 2024

BUY
$32.18 - $46.57 $23,684 - $34,275
736 New
736 $38 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.